Invention Grant
- Patent Title: Controlled release hydrocodone formulations
-
Application No.: US14673447Application Date: 2015-03-30
-
Publication No.: US09278074B2Publication Date: 2016-03-08
- Inventor: Benjamin Oshlack , Hua-Pin Huang , John Masselink , Alfred P. Tonelli
- Applicant: Purdue Pharma L.P.
- Applicant Address: US CT Stamford
- Assignee: Purdue Pharma L.P.
- Current Assignee: Purdue Pharma L.P.
- Current Assignee Address: US CT Stamford
- Agency: Davidson, Davidson & Kappel, LLC
- Main IPC: A61K9/48
- IPC: A61K9/48 ; A61K9/00 ; A61K9/16 ; A61K9/20 ; A61K9/28 ; A61K9/50 ; A61K31/485

Abstract:
A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C12/Cmax ratio of 0.55 to 0.85, said dosage form providing a therapeutic effect for at least about 12 hours.
Public/Granted literature
- US20150216810A1 CONTROLLED RELEASE HYDROCODONE FORMULATIONS Public/Granted day:2015-08-06
Information query